Fibrocell Science, Inc. To Report Second Quarter 2014 Financial And Operating Results, And Host Conference Call And Webcast On August 11, 2014

Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that it will report second quarter and first half 2014 financial and operating results on August 11, 2014. David Pernock, chairman and chief executive officer of Fibrocell Science, will host the conference call and webcast at 8:30 a.m. EDT, August 11, 2014.

Help employers find you! Check out all the jobs and post your resume.